Joseph Rucker

Joe leads new technology advancements and preclinical development of Integral Molecular’s therapeutic antibody assets. He is a co-founder of Integral Molecular and an inventor of the company’s founding technology, the Lipoparticle. He is an inventor on over 10 of the company’s patents and the principal investigator on many of Integral Molecular’s NIH-funded projects.

Joe brings more than 30 years of experience in membrane proteins, antibodies, and viruses, and has published over 40 articles in high-profile journals including Cell, Science, and Nature. Prior to joining Integral Molecular, Joe was an Assistant Professor in the Department of Chemistry at Villanova University. As a post-doc at the University of Pennsylvania, he was involved in leading the discovery of the GPCR CCR5 as an HIV coreceptor. Joe earned his Ph.D. in Chemistry from the University of California, Berkeley and his B.A. at Haverford College.